Researchers have discovered a regulator that could lead to new therapies for lowering unhealthy levels of cholesterol and fats. The team of scientists from the Harvard School of Public Health demonstrated that turning off the regulatory molecule known as XBP1 dramatically reduced blood levels of cholesterol and triglyceride fats in an animal model. There were also no apparent adverse effects on the liver.
See all
